143 related articles for article (PubMed ID: 402175)
41. Metabolism of monoamines and diamines in hyperthyroid and hypothyroid rats.
Sourkes TL; Missala K; Bastomsky CH; Fang TY
Can J Biochem; 1977 Aug; 55(8):789-95. PubMed ID: 890575
[TBL] [Abstract][Full Text] [Related]
42. Chronic administration of type A monoamine oxidase inhibitors increases duration of thiopentone anaesthesia in the rat.
Mason ST
Physiol Behav; 1985 Aug; 35(2):201-3. PubMed ID: 4070383
[TBL] [Abstract][Full Text] [Related]
43. Role of amine oxidase expression to maintain putrescine homeostasis in Rhodococcus opacus.
Foster A; Barnes N; Speight R; Morris PC; Keane MA
Enzyme Microb Technol; 2013 Apr; 52(4-5):286-95. PubMed ID: 23540932
[TBL] [Abstract][Full Text] [Related]
44. Inhibition of serum diamine oxidase discloses a constitutive putrescine release from cultured vascular smooth muscle cells.
Nilsson BO; Kockum I; Rosengren E
Inflamm Res; 1999 Apr; 48(4):176-80. PubMed ID: 10344467
[TBL] [Abstract][Full Text] [Related]
45. Inhibition of rat fat cell lipolysis by monoamine oxidase and semicarbazide-sensitive amine oxidase substrates.
Visentin V; Prévot D; Marti L; Carpéné C
Eur J Pharmacol; 2003 Apr; 466(3):235-43. PubMed ID: 12694806
[TBL] [Abstract][Full Text] [Related]
46. Effects of monoamine oxidase inhibitors on the acid metabolites of some trace amines and of dopamine in the rat striatum.
Dyck LE; Durden DA; Boulton AA
Biochem Pharmacol; 1993 Mar; 45(6):1317-22. PubMed ID: 8466551
[TBL] [Abstract][Full Text] [Related]
47. Enhancement of rat brain cytosolic monoamine oxidase activity by clorgyline. Comparison with (-)-deprenyl and MDL 72145.
Azam M; Jain S; Baquer NZ
Biochem Pharmacol; 1990 Nov; 40(10):2215-8. PubMed ID: 2123104
[TBL] [Abstract][Full Text] [Related]
48. Putrescine catabolism in mammalian brain.
Seiler N; Al-Therib MJ
Biochem J; 1974 Oct; 144(1):29-35. PubMed ID: 4156831
[TBL] [Abstract][Full Text] [Related]
49. Studies on the metabolism of dimethylnitrosamine in vitro by rat-liver preparations. II. Inhibition by substrates and inhibitors of monoamine oxidase.
Lake BG; Harris RA; Collins MA; Cottrell RC; Phillips JC; Gangolli SD
Xenobiotica; 1982 Sep; 12(9):567-79. PubMed ID: 6818776
[TBL] [Abstract][Full Text] [Related]
50. Reduction of fat deposition by combined inhibition of monoamine oxidases and semicarbazide-sensitive amine oxidases in obese Zucker rats.
Carpéné C; Iffiú-Soltesz Z; Bour S; Prévot D; Valet P
Pharmacol Res; 2007 Dec; 56(6):522-30. PubMed ID: 17977742
[TBL] [Abstract][Full Text] [Related]
51. Human kidney diamine oxidase: inhibition studies.
Shindler JS; Bardsley WG
Biochem Pharmacol; 1976 Dec; 25(24):2689-94. PubMed ID: 827296
[No Abstract] [Full Text] [Related]
52. Effect of inhibitors of monoamine oxidase on various enzymes and on the storage of monoamines.
GEY KF; PLETSCHER A; BURKARD W
Ann N Y Acad Sci; 1963 Jul; 107():1147-51. PubMed ID: 13947443
[No Abstract] [Full Text] [Related]
53. The nature of the inhibition of rat liver monoamine oxidase types A and B by the acetylenic inhibitors clorgyline, l-deprenyl and pargyline.
Fowler CJ; Mantle TJ; Tipton KF
Biochem Pharmacol; 1982 Nov; 31(22):3555-61. PubMed ID: 6817759
[TBL] [Abstract][Full Text] [Related]
54. Guanabenz as inhibitor of copper-containing amine oxidases.
Banchelli G; Bertocci B; Raimondi L; Soldani G; Del Tacca M; Buffoni F
Agents Actions; 1986 Apr; 18(1-2):46-8. PubMed ID: 3088929
[TBL] [Abstract][Full Text] [Related]
55. Mitochondrial monoamine oxidase of rat liver: reversible qualitative alterations in catalytic properties.
Veryovkina IV; Samed MM; Gorkin VZ
Biochim Biophys Acta; 1972 Jan; 258(1):56-70. PubMed ID: 5058405
[No Abstract] [Full Text] [Related]
56. Monoamine oxidase inhibitors inhibit [3H]quinpirole binding in rat striatal membranes.
Levant B; Grigoriadis DE; DeSouza EB
Eur J Pharmacol; 1993 Jul; 246(2):171-8. PubMed ID: 8104153
[TBL] [Abstract][Full Text] [Related]
57. Limitation of adipose tissue enlargement in rats chronically treated with semicarbazide-sensitive amine oxidase and monoamine oxidase inhibitors.
Carpéné C; Abello V; Iffiú-Soltész Z; Mercier N; Fève B; Valet P
Pharmacol Res; 2008 Jun; 57(6):426-34. PubMed ID: 18539478
[TBL] [Abstract][Full Text] [Related]
58. [Inhibition of monoamine oxidase and diamine oxidase by furazolidone (Furoxon). Pharmacologic and biochemical studies in man].
Palm D; Magnus U
Klin Wochenschr; 1968 Jul; 46(13):720-8. PubMed ID: 4389812
[No Abstract] [Full Text] [Related]
59. Polyamine levels and diamine oxidase activity in hypertrophic heart of spontaneously hypertensive rats and of rats treated with isoproterenol.
Perin A; Sessa A; Desiderio MA
Biochim Biophys Acta; 1983 Feb; 755(3):344-51. PubMed ID: 6218830
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.
Fisar Z; Hroudová J; Raboch J
Neuro Endocrinol Lett; 2010; 31(5):645-56. PubMed ID: 21200377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
